science
plus
.abes.fr
|
explorer
À propos de :
http://hub.abes.fr/oup/periodical/ajh/1999/volume_12/issue_s4/w
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Issue
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Issue
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Issue
Is Part Of
http://hub.abes.fr/oup/periodical/ajh/1999/volume_12
has manifestation of work
http://hub.abes.fr/oup/periodical/ajh/1999/volume_12/issue_s4/m/print
http://hub.abes.fr/oup/periodical/ajh/1999/volume_12/issue_s4/m/web
Date Copyrighted
1999
Rights
© 1999 by the American Journal of Hypertension, Ltd.
issue
S4
Rights Holder
American Journal of Hypertension, Ltd.
is
Is Part Of
of
Eicosapentaenoic acid is a potent inhibitor of angiotensin II-induced calcium signals in vascular smooth muscle cells
No effect of beta-blockade on the secondary, heart rate-related increase in blood pressure caused by Ang II infusions in conscious rats
Long-term angiotensin AT1 receptor blockade with fonsartan increases lifespan of hypertensive rats
Randomized, prospective dose-comparability study of amlodipine or nifedipine gits in hypertension
Different effects of calcium channel blockers on renal damage development in the fawn-hooded hypertensive rat
Physical activity as a determinant of diurnal blood pressure variation.
Differential effects of valsartan (V) and lisinopril (L) on potassium [K+] homeostasis in hypertensive patients with nephropathy
Renal hemodynamic and hormonal responses to the angiotensin II antagonist, candesartan: The angiotensin II-renin short feedback loop.
E012: Divergent effects of dihydropyridine and phenylalkylamine calcium antagonist on plasma norepinephrine before and after cold pressor test in mild to moderate hypertension.
I009: Dual effects of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men
I011: Insulin resistance in hypertensive Afro-venezuelan subjects.
I013: Hypotensive effect of lacidipine vs lisinopril in hypertensive NIDDM patients.
I031: Effects of supplemented Taohe Chengqi Decoction in treating insulin resistance in rats with non-insulin dependent diabetes mellitus
J002: Aldosterone reverses the protective effects of adrenalectomy against end-organ damage in stroke-prone spontaneously hypertensive rats
J003: Oxidative stress in hypertensive with left ventricular hypertrophy= preliminary report.
J027: Do patients with de novo hypertension differ from those with previously known hypertension when malignant phase hypertension occurs?
K031: High blood pressure levels prevalence in children from Bragança Paulista — SP — Brasil
K034: Clinical sequelae after becoming lost-to-follow-up in a tertiary hypertension clinic.
K038: Birth weight and cardiovascular risk factors in Japanese young adults.
A001: Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes.
A007: Effects of cholesterol on interaction of angiotensin II and insulin on dorsal hand vein.
A008: Inhibitory effect of PD098059 on angiotensin II induced-mitogen activated protein kinase activation.
A009: Baseline blood pressure predicts constrictor effects of angiotensin II on dorsal hand vein.
A011: Angiotensin II induced greater venoconstriction in hypertensives
A018: Central effects of AT1 receptor antagonism by eprosartan - in vitro autoradiography in the brain.
B006: Hypertension in cafeteria fed rats: alteration in renal α2-adrenoceptor subtype
B014: Comparison of prograf and neoral immunosuppression on plasma and urinary angiotensin peptides in adult kidney transplant recipients
C013: Heart rate and blood pressure variability in normotensive offspring of hypertensive subjects
D010: Effects of metformin on arterial vascular sympathetic nerve endings
D013: Gender differences in venodilatory effect of diltiazem in healthy normotensive individuals
D024: Treatment of hypertension with valsartan (V) alone or combined with spironolactone (S)
D025: Long-term effects of losartan on hypertension and left ventricular mass in elderly patients
D036: In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor
D080: Effects of ACE-inhibitors on the vegetative tone of the cardiovascular system in hypertensive patients
D099: Enalapril versus valsartan at old patients: 24-hour antihypertensive efficacy and influence on quality of life
A001: Blood pressure, temperature, viscosity and erythrocyte deformability relations.
A011: Ambulatory blood pressure monitoring and clinical characteristics of the true and white coat resistant hypertension.
A017: Effect of sildenafil on blood pressure and heart rate in healthy normotensive volunteers.
A039: Chronotherapy of dipper and non-dipper type hypertension with bunazisin-retard : Morning versus evening administration.
A041: Heart rate variability and arrhythmias in essential hypertension with and without nocturnal blood pressure fall
B002: Antihypertensive treatment and aortic internal diameter in SHR.
B005: Increased αvβ3 integrins in mesenteric resistance arteries from SHR: Effect of anti-hypertensive therapy
E008: Patterns and determinants of LVH in CAPD.
E011: Efficacy of lisinopril vs losartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients.
E019: Left ventricular structure and function in pregnancy induced hypertension
L001: Blood pressure reactivity to mental stress and sustained hypertension after six months of follow-up. Hospitalet study.
L003: Cardiovascular risk factors: blood pressure and body weight in Hispanic school aged children.
Thursday, May 20, Astor Ballroom, 5:00 PM: Theme I: Genetic animal models in hypertension: Where do things stand and where are they going?
Friday, May 21, Astor Ballroom, 5:00 PM: Theme I: Kidney dysfunction as a cause and a consequence of hypertension
Friday, May 21, Astor Ballroom, 5:00 PM: Theme I: Kidney dysfunction as a cause and a consequence of hypertension
Saturday, May 22, Broadway Ballroom, 9:30 AM: Plenary session III: Why is hypertension so poorly controlled?
Saturday, May 22, Broadway Ballroom North, 12:30 PM: Theme II: Debate: Angiotensin II receptor blockers should replace ACE inhibitors
Endothelin and cardiac natriuretic peptides in heart failure
Src modulates Ang II-mediated Ca2+ signaling in human vascular smooth muscle cells
Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell
High sodium intake is associated with improved insulin sensitivity in sodium sensitive as compared with sodium resistant hypertension prone men
Role of vasopressin in vascular remodeling of DOCA-salt-treated brattleboro rats.
Intrarenal angiotensin levels in hypertensive rats with reduced renal mass
Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney
Marital factors over 3 years influence blood pressure and left ventricular mass in mildly hypertensive patients
Regression of left ventricular hypertrophy on serial echocardiography in the hypertension optimal treatment study.
A004: ACE-I gene polymorphism and arterial hypertension: Lack of association in afro-venezuelan populations
D001: Long term effect of bilateral ovariectomy on endothelial function in spontaneously hypertensive rats. Role of nitric oxide.
D006: Compensatory rise in vascular NO synthase (NOS) in young and severe NOS fall in old SHR: Prevention with losartan therapy
G008: Cellular calcium/magnesium antagonism in primary hypertension
I001: High glucose and hyperinsulinemia inhibit MKP-1 expression in aortic smooth muscle cells by blocking the induction of iNOS
I024: Effects of weight loss on multiple cardiovascular disease risk factor reduction: One-year of treatment with Orlistat.
J023: Early changes in left ventricular function and geometry in patients with mild mitral or aortic regurgitation. the life study
J034: Screening of elderly patients for abdominal aortic aneurysms during echocardiography
K005: Is the prevalence of hyperuricemia in essential hypertension decreasing?
K047: Yield of renal arteriography (RA) in the evaluation of pediatric hypertension.
A017: The association between polymorphism of renin-angiotensinogen genes and Chinese essential hypertensives
B016: Effects of treatment with ramipril on elderly patients with diabetes mellitus and albuminuria -
D006: In vivo blockade of angiotensin II receptor binding in rat kidney: comparison of candesartan cilexetil with losartan
D022: The effect of antihypertensive therapy with amlodipine on the morning catecholamines, angiotensin- converting enzyme and insulin increments
D048: Pediatric use of ace-inhibitors - a review from 1979 to 1996
D057: How does the CA antagonist influence the relationship between blood pressure and physical activity by treating on short acting or long acting one?
D065: Reduced diuretic-induced hypokalemia with valsartan in combination with HCTZ
D076: Comparison of the angiotensin II receptor blockade induced by tasosartan and its active metabolite enoltasosartan in healthy subjects.
D085: Treatment with doxazosin in hypertensive patients with dyslipidemia in Primary Care Centers.
D087: Quinapril/HCTZ combination rather than low-dose HCTZ should be recommended as first line antihypertensive therapy in black patients with mild to moderate hypertension.
D095: Use of Angiotensin (AII) antagonist losartan in patient treated with DSC LDL-apheresis.
D103: Integrated cardiac and metabolic effects of the beta-1-selective blocker nebivolol in physically active patients with essential hypertension.
D110: Perindopril in elderly hypertensives
E010: ABCD-2V: Appropriate blood pressure control in diabetes—part 2 with valsartan
E018: Second Australian national blood pressure study (ANBP2) - progress report.
E023: The metabolic syndrome in hypertensive men: High risk of cardiovascular disease that may be reduced.
A061: Effect of vigilance on arterial blood pressure
B006: Effects of fluvastatin treatment on structure and function of resistant vessels in spontaneously hypertensive rats
C006: Ang II-induced proto-oncogene expression is altered in vascular smooth muscle cells from essential hypertensive patients — implications in vascular remodeling.
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 9
Go
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata